Understanding Alpha Stat/pH Stat. Cardiopulmonary Bypass Management. Protamine - Neutralize Heparin
Understanding Alpha Stat/pH Stat. Cardiopulmonary Bypass Management. Protamine - Neutralize Heparin

Understanding Alpha Stat/pH Stat. Cardiopulmonary Bypass Management. Protamine - Neutralize Heparin [284]

  • Faculty: Jordan Hoffman, MD
  • Date: July 7th, 2021 1:45 am
  • CE’s: 3.4 CEs
  • Price: $51
  • Category 1 SDCE CEU
Buy Course
Course Rating:
(0 Reviews)

Latest Reviews

View All

Course description

Vanderbilt University Medical Center; Department of CV Surgery: Faculty Forum: 
Understanding alpha stat and pH stat 
Faculty: Katie Faella CCP, LCP, FPP, J. Hoffman, MD, Matt Warhoover, CCP, A. Lepore, CCP 
Tammy Sparacino Journal Club: “Commentary: Taking the next step in cardiopulmonary bypass management Cardiopulmonary bypass technology continues to advance. More sophisticated monitoring strategies could be beneficial in improving the outcomes of patients for whom open heart surgery is necessary." 
John Ingram Knowledge Nuggets: How Does Protamine Really Neutralize Heparin? 
Register and watch for free @ https://library.perfusioneducation.com 
IV Dosage and Rate Calculator - https://mediweb.us/iv-medication-calculator/ 
Subscribe to our podcast: 

Meet Your Instructor

Jordan Hoffman, MD

Jordan Hoffman, MD

Dr. Hoffman was born in New Orleans, Louisiana and was raised in Los Angeles, California. His undergraduate degree is from Rice University in Houston, Texas. He attended medical school at Tulane University in New Orleans, Louisiana and simultaneously received his MPH from the Tulane School of Public Health and Tropical Medicine. Dr. Hoffman’s general surgical training began at Emory and Grady Hospitals in Atlanta, Georgia followed by a fellowship in Cardiothoracic Surgery at University of Colorado in Denver, Colorado. 

Dr. Hoffman's clinical interests include end-stage heart and lung disease, pulmonary hypertension, mechanical support and devices, as well as aortic surgery. His research interests involve studying heart failure physiology in patient’s undergoing LVAD placement and novel therapies to extend the viability of donor hearts.

Read full bio